TSX: ATD - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Read More

Retail Industry News

Couche-Tard (TSX: ATD) delivers $740m Q2 profit as fuel margins and foodservice lift earnings amid volume pressure

Alimentation Couche-Tard posts $740 million Q2 FY26 profit with strong fuel margins and retail momentum. Find out how its global strategy is unfolding.

November 25, 2025

web analytics